In today’s Bluecrest news, Target Ovarian Cancer has announced how many cases of Ovarian cancer are missed by GPs, as awareness is not as good as it should be. The coverage states how research found that women were ‘dying needlessly’ because they were ‘fobbed off’ by doctors who attributed symptoms to other issues such as digestion problems, the menopause or stress.
No screening test is perfect – and there are always ‘false positives’ and ‘false negatives’. However, once you are aware of both the benefits and limitations of screenings for Ovarian Cancer, it may be worth considering whether Bluecrest Health Screening tests may be right for you, such as the CA125 test. In 90% of women with ovarian cancer CA-125 levels will be raised. A raised level does not diagnose ovarian cancer however, and it is important to remember that further tests will be required for a full diagnosis. As outlined in further news coverage today, early diagnosis is crucial with all forms of cancer – and this BBC piece also comments on how “NHS cancer testing service is ‘at breaking point’”
The good news is that 90% of women diagnosed with early stages ovarian cancer will be alive in 5 years. Bluecrest Health Screening supports the goal of ensuring that as many as possible are picked up earlier.
Read the full Target Ovarian Cancer report.